Skip to main content
OpenTrials

Clinical trial condition

Gliosarcoma

Explore clinical trials studying Gliosarcoma. Study availability and eligibility vary by location and protocol.

373 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Gliosarcoma trial results

Completed

Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma

NCT00027625

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma

NCT00010049

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +22 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy

NCT00004868

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +20 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00770471

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +13 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma

NCT00005859

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

CCI-779 in Treating Patients With Malignant Glioma

NCT00022724

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

NCT00006358

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

NCT00025675

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +22 more
Locations
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • NCI - Neuro-Oncology Branch Bethesda, Maryland, United States
View Trial Details
Completed

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme

NCT01648348

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +23 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Saint Jude Medical Center Fullerton, California, United States
  • Saint Joseph Hospital - Orange Orange, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 308 locations
View Trial Details
Completed

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00621686

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Cancer Care Associates Fresno, California, United States
  • Front Range Cancer Specialists Fort Collins, Colorado, United States
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
View all 204 locations
View Trial Details

Related conditions